ГОСТ Р ИСО 20776-1-2010 Клинические лабораторные исследования и диагностические тест-системы in vitro. Исследование чувствительности инфекционных агентов и оценка функциональных характеристик изделий для исследования чувствительности к антимикробным средствам. Часть 1. Референтный метод лабораторного исследования активности антимикробных агентов против быстрорастущих аэробных бактерий, вызывающих инфекционные болезни

[1]

de I'Antibiogramme de la de Microbiologie. (1966), Technical recommendations for in vitro susceptibility testing, Clin Microbiol Infect. 2 (suppl 1): S 11-25

[2]

Deutsches Institut Normung (1999), Medical microbiology - Susceptibility testing of pathogens to antimicrobial agents - Part 4: Evaluation classes of the minimum inhibitory concentration, DIN, Berlin, pp. 58940-4

[3]

OLSSON-LILJEQUIST, В., LARSSON, P., WALDER, M. and MIORNER, H. (1997), Antimicrobial susceptibility testing in Sweden III. Methodology for susceptibility testing, Scand J Infect Dis. 105 (suppl): 13-23

[4]

ANDREWS, J.M. (2001), Determination of minimum inhibitory concentrations, J Antimicrob Chemother.48 Suppl. S1: 5-16 (for latest version, see http://www.bsac.org.uk/_db/_documents/Chapter_two.pdf)

[5]

Clinical and Laboratory Standards Institute (2006), Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically, 7th edn. Approved Standard M7-A7, Wayne, PA

[6]

European Committee on Antimicrobial Susceptibility Testing. (2003), Determination of minimuminhibitory concentrations (MICs) of antibacterial agents by broth microdilution, EUCAST DiscussionDocument E.Def 5.1. Clinl Microbiol Infect; 9 (issue 7 insert): 1-10 (see http://www.escmid.org/Seviware/Script/SvFiles.asp?Ref=359)

[7]

Clinical and Laboratory Standards Institute (2006), Performance Standards for Antimicrobial Susceptibility Testing, 16th edn. Informational Supplement M100-S16, Wayne, PA

[8]

ERICSSON, H.M., SHERRIS, J.С. (1971), Antibiotic sensitivity testing. Report of an internationalcollaborative study, Acta Pathol Microbiol Scand. Sect В 217 (suppl): 1-90

[9]

European Committee on Antimicrobial Susceptibility Testing (2000), Determination of minimum nhibitory concentrations (MICs) of antibacterial agents by agar dilution, EUCAST Definitive DocumentE.Def 3.1 (for latest version, see http://www.escmid.org/sites/science/eucast/pages.asp?m=Programmes)

[10]

MUELLER, J.H. and HINTON, J. (1941), A protein-free medium for primary isolation of the gonococcus and meningococcus, Proc Soc ExperBiol Med. 48: 330

[11]

MORRISON, G.H. (1969), Critical Reviews in Analytical Chemistry, (14) 28A, CRC Press, Boca Raton, Florida

[12]

BARRY, A.L., MILLER, G.H., THORNSBERRY, С et al. (1987), Influence of cation supplements on activity of netilmicin against Pseudomonas aeruginosa in vitro and in vivo, Antimicrob Agents Chemother. 31:1514-1518

[13]

BARRY, A.L, RELLER, LB., MILLER, G.H. et al. (1992), Revision of standards for adjusting the cation content of Mueller-Hinton broth for testing susceptibility of Pseudomonas aeruginosa to aminoglycosides, J. Clin Microbiol. 30: 585-589

[14]

FUCHS, PC, BARRY, A.L. and BROWN, S.D. (2000), Daptomycin susceptibility tests: interpretive criteria, quality control and effect of calcium on in vitro tests, Diag Microbiol Infect Dis. 38: 51-58

[15]

DALY, J.S., DODGE, R.A., GLEW, R.H., SOJA, D.T., DELUCA, B.A and HEBERT, S. (1997), Effect of zinc concentration in Mueller-Hinton agar on susceptibility of Pseudomonas aeruginosa to imipenem, J. Clin Microbiol. 35:1027-1029

[16]

European Committee on Antimicrobial Susceptibility Testing, Clinical breakpoints and epidemiological cut-off values (for latest version, see http://www.escmid.orq/sites/science/eucast/paqes.asp?m=Proqrammes)